Active-ingredient Dossier
Atropine Sulfate Monohydrate
Active-ingredient Dossier for Atropine Sulfate Monohydrate (anticholinergic agent). Australian brands, products, PBS listings, PBAC outcomes — compiled…
- Brand: Atropine
- Brand: ATROPT
- Brand: ATROPINE JUNO
- Brand: LOFENOXAL
- Brand: LOMOTIL
- Brand: Atropine
- Therapeutic area: Gastroenterology
- Therapeutic area: Other
- Therapeutic area: Cardiology
What is
Atropine Sulfate Monohydrate Atropine Sulfate Monohydrate is an anticholinergic agent.
Australian brands containing
Atropine Sulfate Monohydrate — Atropine — ATROPT — ATROPINE JUNO — EIKANCE — LOFENOXAL — LOMOTIL — MINIMS
Therapeutic areas
Atropine Sulfate Monohydrate is registered in multiple therapeutic areas: Gastroenterology (4 brands), Ophthalmology (3 brands), Complementary Medicine (1 brand), Respiratory (1 brand), and Other (1 brand).
Sponsor landscape
The ingredient is marketed by seven sponsors: Aspen Pharmacare, iNova Pharmaceuticals, Pfizer (Perth), Juno Pharmaceuticals, Haleon, and Proqualix Pty Ltd (in Administration).
PBS and regulatory activity
Two brands containing Atropine Sulfate Monohydrate have PBS-listed items, with the latest PBS schedule date of 1 May 2026.